AMPLY Discovery

AMPLY Discovery

Private
BelfastHealthcare & Life Scienceshttps://amplydiscovery.com/

Last Round

Strategic

Feb 11, 2026

Total Funding Raised

$4.33M

Momentum Score

25 /100

Company Overview

AMPLY Discovery is a biotechnology company that uses its proprietary AI platform, AMPLYfolioAI, to discover novel biologic drugs for diseases such as cancer and drug-resistant infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

ai drug discoverybiologic drug discoverygenerative biologysynthetic biologyai discovery platformAI for biologyRNAi therapyantimicrobial peptidesAMPsin-silico discoverynext-generation sequencingNGSdrug candidate licensingoncology drug discoverydrug-resistant infection therapydrug discovery studiobio-printing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AMPLY Discovery Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AMPLY Discovery Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
StrategicFeb 11, 2026
SeedMay 1, 2025
GrantFeb 12, 2024
AcceleratorDec 9, 2023
Pre SeedSep 27, 2022

Key People

Founding team and executive leadership

Ben Thomas

Chief Executive Officer

Executive Team

AMPLY Discovery Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    Raised a strategic round with Keeps Biomed participating.

  • Jul 7, 2025

    Monthly visitors grew 124% MoM, reaching 1.4K.

AMPLY Discovery Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AMPLY Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AMPLY Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelfast
Employee Range7
Year Founded2021
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.